Crossmark

Development of Liposomal Formulation for Controlled Delivery of Valacyclovir: an In Vitro Study

Crossref DOI link: https://doi.org/10.1007/s12247-022-09706-1

Published Online: 2023-01-05

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mallick, Ankita https://orcid.org/0000-0002-0043-8905
Sahu, Ranabir https://orcid.org/0000-0002-2229-1019
Nandi, Gouranga https://orcid.org/0000-0001-9571-3641
Dua, Tarun Kumar https://orcid.org/0000-0001-5136-7564
Shaw, Tapan Kumar https://orcid.org/0000-0001-8585-7641
Dhar, Ankita https://orcid.org/0000-0002-7228-0801
Kanu, Aditya https://orcid.org/0000-0001-6792-6383
Paul, Paramita https://orcid.org/0000-0002-8077-9530
License Information

Text and Data Mining valid from 2023-01-05

Version of Record valid from 2023-01-05
More Information

Article History

Accepted: 20 December 2022

First Online: 5 January 2023

Declarations

:

: The authors declare no competing interests.